Ibm Retirement Fund Biogen Inc. Transaction History

Ibm Retirement Fund

$72.1 Million
Q2 2022

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$187.54 - $223.02 $437,530 - $520,305	-2,333 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $27,127 - $34,179	-140 Reduced 5.66%	2,333 $491,000
Q4 2021 Jan 19, 2022	SELL	$223.92 - $287.77 $397,681 - $511,079	-1,776 Reduced 41.8%	2,473 $593,000
Q3 2021 Oct 05, 2021	BUY	$282.99 - $369.05 $4,244 - $5,535	15 Added 0.35%	4,249 $1.2 Million
Q2 2021 Jul 12, 2021	SELL	$259.0 - $414.71 $259,259 - $415,124	-1,001 Reduced 19.12%	4,234 $1.47 Million
Q1 2021 Apr 22, 2021	SELL	$242.95 - $284.63 $145,770 - $170,778	-600 Reduced 10.28%	5,235 $1.46 Million
Q4 2020 Jan 25, 2021	BUY	$236.26 - $355.63 $72,768 - $109,534	308 Added 5.57%	5,835 $1.43 Million
Q3 2020 Oct 16, 2020	BUY	$264.77 - $305.71 $351,349 - $405,677	1,327 Added 31.6%	5,527 $1.57 Million
Q2 2020 Jul 08, 2020	SELL	$258.66 - $342.55 $100,360 - $132,909	-388 Reduced 8.46%	4,200 $1.12 Million
Q1 2020 Apr 07, 2020	BUY	$268.85 - $341.04 $413,760 - $524,860	1,539 Added 50.48%	4,588 $1.45 Million
Q4 2019 Jan 07, 2020	SELL	$220.06 - $304.07 $37,850 - $52,300	-172 Reduced 5.34%	3,049 $905,000
Q3 2019 Nov 06, 2019	SELL	$217.44 - $243.88 $39,356 - $44,142	-181 Reduced 5.32%	3,221 $750,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $1,096 - $1,208	-5 Reduced 0.15%	3,402 $796,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $10,185 - $15,931	-47 Reduced 1.36%	3,407 $805,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $65,447 - $82,896	-235 Reduced 6.37%	3,454 $1.04 Million
Q3 2018 Nov 07, 2018	SELL	$293.51 - $383.83 $220,719 - $288,640	-752 Reduced 16.93%	3,689 $1.3 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $163,010 - $194,274	-633 Reduced 12.48%	4,441 $1.29 Million
Q1 2018 May 10, 2018	SELL	$260.13 - $367.91 $37,978 - $53,714	-146 Reduced 2.8%	5,074 $1.39 Million
Q4 2017 Feb 07, 2018	SELL	$307.64 - $344.58 $21,534 - $24,120	-70 Reduced 1.32%	5,220 $1.82 Million
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $1.49 Million - $1.74 Million	5,290	5,290 $1.82 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.

Account